Recently, next-generation sequencing studies have identified novel recurrent pre-B-ALL genomic lesions in genes such as ABL1/2, JAK2, ZNF384, MEF2D and DUX4,3,4 though the incidence and prognostic significance for some of these lesions are yet to be confirmed. Here, ZNF384 is linked to acute lymphoblastic leukemia.